Mississauga, Ontario — November 4, 2025 — Leads & Copy — MyndTec Inc. (CSE: MYTC) has closed the seventh tranche of its non-brokered private placement, raising $52,451.25 through the issuance of 262,027 Units at $0.20 per Unit.
Each Unit includes one common share and one-half of a common share purchase warrant. Each whole warrant allows the holder to buy one common share at $0.24 for 36 months.
The company plans to use the funds for general corporate purposes, such as working capital, corporate development, machine learning model development, debt settlement, investor relations, and marketing.
The Units are subject to a four-month statutory hold in Canada and transfer restrictions in the United States. The closing of the tranche is pending final approval from the Canadian Securities Exchange.
Related parties of MyndTec participated in the private placement, but their participation is exempt from certain requirements due to the company’s securities not being listed on a specified market and the value of Units issued to related parties not exceeding $2,500,000.
MyndTec is a medical technology company focused on neurostimulation to improve treatments for central nervous system disorders. They developed the MyndMove™ system, which uses neuroplasticity to stimulate new neural pathways.
Craig Leon, CEO, investor.relations@myndtec.com, Tel: (905) 919-3144
Source: MyndTec Inc.
